The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.75
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Changes to Warrant Terms

18 Jan 2022 07:00

RNS Number : 7425Y
Sabien Technology Group PLC
18 January 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

18 January 2022

Sabien Technology Group plc

("Sabien" or the "Company")

Changes to Warrant Terms

 

Sabien Technology Group plc, a Company focused on a Green Aggregation Strategy announces that the board of directors of the Company (the "Board") yesterday agreed to amend the terms of the warrants originally announced on 20 January 2021 (the "Warrants"). Following last year's share capital consolidation and those warrant exercises that have taken place so far, there are 8,283,331 Warrants outstanding. The Warrant terms will be amended as follows:

· The final exercise date will be extended from 19 January 2022 to 4 February 2022; and

· Any Warrant holder who exercises at least 25% of their Warrants between 20 January 2022 and 2 February 2022 will be granted one Bonus Warrant for each Warrant exercised.

All other Warrant terms will remain unchanged. The Bonus Warrants will have the following key terms:

· An exercise period which expires on 5 February 2023;

· An exercise price of 45 pence per new ordinary share of 3 pence each in the capital of the Company ("Ordinary Shares");

· Transferrable (however no application will be made for admission to trading on any recognised trading platform); and

· The Bonus Warrants will have a call option whereby in the event that the Ordinary Shares closes above 40 pence per Ordinary Share (mid-market closing price on AIM), the Company has the right (but not the obligation) at any time thereafter to call warrant holders to exercise all warrants held by them within 7 days. Any warrants not exercised when so required by the Company will automatically expire at the end of the 7-day period.

 

Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

+44 20 7993 3700

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

+44 20 3328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 20 7469 0930

 

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

A copy of this announcement will be available from the Company's website at www.sabien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBVARUAUAAUR
Date   Source Headline
20th Mar 20207:00 amRNSHalf-year Report
18th Mar 20207:00 amRNSChange of Adviser
20th Jan 20207:30 amRNSSuspension - Sabien Technology Group plc
20th Jan 20207:30 amRNSStatement re Press Comment
10th Jan 20202:00 pmRNSPrice Monitoring Extension
10th Jan 20201:30 pmRNSIssue of Equity
10th Jan 202010:15 amRNSHolding(s) in Company
8th Jan 20201:15 pmRNSResult of Meeting
19th Dec 201912:30 pmRNSApplication for admission
17th Dec 20194:35 pmRNSNotice of GM
16th Dec 201912:30 pmRNSIssue of Equity
5th Dec 20194:30 pmRNSResult of AGM
13th Nov 20195:15 pmRNSNotice of AGM
6th Nov 20197:00 amRNSHolding(s) in Company
5th Nov 20197:00 amRNSDirectorate Change
4th Nov 201911:30 amRNSHolding(s) in Company
1st Nov 20191:00 pmRNSHolding(s) in Company
31st Oct 20195:00 pmRNSHolding(s) in Company
29th Oct 201911:05 amRNSSecond Price Monitoring Extn
29th Oct 201911:00 amRNSPrice Monitoring Extension
29th Oct 20199:05 amRNSSecond Price Monitoring Extn
29th Oct 20199:00 amRNSPrice Monitoring Extension
18th Oct 20192:47 pmRNSCorporate Update
30th Sep 20192:37 pmRNSTotal Voting Rights
27th Sep 20197:00 amRNSFinal Results
24th Sep 20197:00 amRNSBoard Changes
20th Sep 201910:51 amRNSHolding(s) in Company
10th Sep 201910:59 amRNSHolding(s) in Company
10th Sep 201910:56 amRNSHolding(s) in Company
3rd Sep 20197:00 amRNSBoard changes, subscription and trading update
28th Jun 20193:38 pmRNSHolding(s) in Company
11th Jun 20191:46 pmRNSNew contract award and trading update
30th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSPlacing
2nd Apr 20197:00 amRNSCorporate Update - Contract Win
14th Feb 20197:00 amRNSHalf-year Report
12th Feb 201910:29 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
12th Feb 201910:24 amRNSHolding(s) in Company
4th Feb 20193:20 pmRNSCorporate Update - Orders Received
17th Jan 20197:00 amRNSDirectorate Change
21st Dec 20182:54 pmRNSResult of AGM and Board change
20th Dec 201810:29 amRNSDirector/PDMR Shareholding
20th Dec 201810:27 amRNSHolding(s) in Company
17th Dec 20183:47 pmRNSHolding(s) in Company
17th Dec 20182:54 pmRNSHolding(s) in Company
17th Dec 20182:50 pmRNSHolding(s) in Company
17th Dec 20182:49 pmRNSHolding(s) in Company
17th Dec 20187:00 amRNSHolding(s) in Company
13th Dec 20182:09 pmRNSResult of General Meeting and Board changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.